Patents by Inventor Barbara Rohm

Barbara Rohm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydroxyflavanones as appetite stimulants
    Patent number: 10561633
    Abstract: The invention relates to compounds of formula (I) or the salts thereof, said compounds of formula (I) being selected from among the group consisting of homoeriodictyol (1), eriodictyol (2), hesperetin (3) and sterubin (4), for use in the treatment of an ailment which can be alleviated or prevented by influencing the serotonin level and the concentration of free fatty acids in the blood.
    Type: Grant
    Filed: July 26, 2015
    Date of Patent: February 18, 2020
    Assignee: SYMRISE AG
    Inventors: Veronika Somoza, Barbara Rohm, Kathrin Liszt, Marc Pignitter, Christina Hochkogler, Jakob Ley, Sabine Widder, Gerhard Krammer
  • Oral compositions
    Patent number: 9468225
    Abstract: Suggested are new compositions for oral ingestion, comprising at least one active agent from the group of alkamides. The compositions which are orally ingested reduce the uptake of free fatty acids in the adipocytes and at the same time stimulate the release of serotonin and dopamine, which leads to a reduction of appetite, a feeling of satiety and a positive mood. In doing so, the new compositions are thus perfectly suitable to counteract any undesired gain of weight.
    Type: Grant
    Filed: February 12, 2014
    Date of Patent: October 18, 2016
    Assignee: Symrise AG
    Inventors: Jakob Ley, Sabine Widder, Veronika Somoza, Barbara Rohm, Matthias Zaunschirm, Gerhard Krammer
  • AROMATIC ALKENOIC ACID DERIVATIVES
    Publication number: 20150259319
    Abstract: What are proposed are primarily aromatic alkenoic acid derivatives of the formula I for use in a therapeutic method as (a) means for reducing appetite and/or (b) means for causing a feeling of satiation and/or as (c) means for reducing energy intake and/or as (d) mood enhancers, and the non-therapeutic use of the aromatic alkenoic acid derivatives of formula I as (a) means for reducing appetite and/or (b) means for causing a feeling of satiation and/or as (c) means for reducing energy intake and/or as (d) mood enhancers.
    Type: Application
    Filed: March 11, 2015
    Publication date: September 17, 2015
    Inventors: Jakob Ley, Katja Obst, Katharina Reichelt, Veronika Somoza, Barbara Rohm
  • ORAL COMPOSITIONS
    Publication number: 20140234412
    Abstract: Suggested are new compositions for oral ingestion, comprising at least one active agent from the group of alkamides. The compositions which are orally ingested reduce the uptake of free fatty acids in the adipocytes and at the same time stimulate the release of serotonin and dopamine, which leads to a reduction of appetite, a feeling of satiety and a positive mood. In doing so, the new compositions are thus perfectly suitable to counteract any undesired gain of weight.
    Type: Application
    Filed: February 12, 2014
    Publication date: August 21, 2014
    Applicant: Symrise AG
    Inventors: Jakob Ley, Sabine Widder, Veronika Somoza, Barbara Rohm, Matthias Zaunschirm, Gerhard Krammer